Alameda County outlines $80 million opioid-settlement plan: jail MAT expansion, mini‑grants, naloxone vending and drug‑checking pilots

Alameda County health officials on Monday detailed how they are spending opioid‑settlement funds — now projected at about $80 million — to expand medication‑assisted treatment (MAT), fund community mini‑grants and deploy public‑access naloxone and drug‑checking services.

Dr. Karen Tribble, the county Behavioral Health Director, said the federal settlement will be paid over many years; the county is operating on an 18‑year distribution assumption and has already received about $23.3 million, of which roughly $10 million has been spent and $4.4 million covered legal fees. She stressed strict auditing and reporting obligations and warned that unused state allocations could revert if not spent according to requirements.

Deputy Director James Wagner described stakeholder engagement — more than 300 participants at multiple public listening sessions — and program priorities: expanded MAT availability (including in the jail), additional detox beds pending a state B CHIP award, an opioid public‑information campaign and community mini‑grants administered through a fiscal agent. Wagner said the county has added 11 recovery‑residence beds and 85 residential substance‑use‑treatment beds and is scaling substance‑use outreach teams.

Dr. Kelly Bowers of 3 Valleys, the fiscal agent for the mini‑grants, said 12 of 41 eligible applications received awards (ranging from roughly $62,000 to $300,000), prioritizing collaboration and projects serving people disproportionately harmed by the opioid crisis. The grants target priority populations including people who are unhoused, justice‑involved residents and vulnerable youth.

On treatment, county presenters said MAT access has expanded dramatically at Santa Rita Jail: in February, over 200 doses of buprenorphine were prescribed at release, and 46 individuals received long‑acting injectable buprenorphine. Officials described the Bridge Clinic at Alameda Health System as a low‑barrier, same‑day access point that will receive settlement support and serve as a linkage site for people released from jail.

Officials also said the county will deploy 45 Naloxone vending boxes to behavioral‑health‑contracted sites and programs; the boxes include user instructions and QR codes linking to training videos. Staff committed to mapping public‑access naloxone locations and expanding community training.

The county is piloting drug‑checking (through contracted partners) to give people information about contents and adulterants in the local street supply; staff said early data show a rise in polydrug overdoses (stimulants mixed with opioids) rather than simple contamination alone, and that drug‑checking helps people make safer choices.

Supervisors asked about the cost and sustainment of long‑acting injectables; presenters said branded, long‑acting medications (SUBLOCADE and another brand) are expensive (hundreds to about $1,000 per injection) and estimated per‑individual program costs that include medication and administration can be several thousand dollars. Staff said some medications are claimable under Medi‑Cal and that settlement dollars are enabling immediate scale‑up while they build sustainability plans.

A public commenter with lived experience credited the injectable SUBLOCADE with saving her life and urged continued access for people released from incarceration.

County staff said they will continue to refine budgets, monitor outcomes and return with updates and metrics to the committee.